Related Experiment Video
Updated: Jan 21, 2026

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
Published on: July 1, 2020
The coenzyme A biosynthetic pathway: A new tool for prodrug bioactivation
Dustin Duncan1, Karine Auclair1
1Department of Chemistry, McGill University, Sherbrooke Street West, Montreal, Quebec, H3A 0B8, Canada.
Abstract:
Prodrugs account for more than 5% of pharmaceuticals approved worldwide. Over the past decades several prodrug design strategies have been firmly established; however, only a few functional groups remain amenable to this approach. The aim of this overview is to highlight the use of coenzyme A (CoA) biosynthetic enzymes as a recently explored bioactivation scheme and provide information about its scope of utility. This emerging tool is likely to have a strong impact on future medicinal and biological studies as it offers promiscuity, orthogonal selectivity, and the capability of assembling exceptionally large molecules.
Related Concept Videos
Amino Acid Biosynthetic Pathways
Cofactors and Coenzymes
Cofactors and Coenzymes
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...
Prodrugs
Prodrugs help overcome...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Role of Reduced Coenzymes NADH and FADH₂

